|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| C12N 9/64 | |||
| G01N 33/573 | |||
| A61K 39/00 |
| (11) | Number of the document | 2820048 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12708473.9 |
| Date of filing the European patent application | 2012-02-29 | |
| (97) | Date of publication of the European application | 2015-01-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/027160 |
| Date | 2012-02-29 |
| (87) | Number | WO 2013/130078 |
| Date | 2013-09-06 |
| (72) |
SMITH, Victoria, US
MCCAULEY, Scott, US
|
| (73) |
Gilead Biologics, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |
| ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |